We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Healthcare 10.88%
3 Consumer Discretionary 10.71%
4 Financials 8.69%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMMT icon
4226
Summit Therapeutics
SMMT
$10.8B
$14K ﹤0.01%
11,391
+2,028
+22% +$2.29K
SPFI icon
4227
South Plains Financial
SPFI
$860M
$14K ﹤0.01%
503
-137
-21% -$3.57K
SYRE icon
4228
Spyre Therapeutics
SYRE
$9.09B
$14K ﹤0.01%
1,075
+447
+71% +$5.52K
VLN icon
4229
Valens Semiconductor
VLN
$210M
$14K ﹤0.01%
3,243
+2,592
+398% +$10.4K
VTEX icon
4230
VTEX
VTEX
$617M
$14K ﹤0.01%
+4,000
New +$15K
WEAV icon
4231
Weave Communications
WEAV
$429M
$14K ﹤0.01%
2,836
-478
-14% -$2.44K
ATXI
4232
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$14K ﹤0.01%
19
+16
+533% +$5.12K
MMV
4233
DELISTED
MultiMetaVerse Holdings Limited Class A Ordinary Share
MMV
$14K ﹤0.01%
1,321
-199
-13% -$2.04K
ORGS
4234
DELISTED
Orgenesis Inc. Common Stock
ORGS
$14K ﹤0.01%
969
+948
+4,514% +$17.8K
TGAN
4235
DELISTED
Transphorm, Inc. Common Stock
TGAN
$14K ﹤0.01%
2,765
+275
+11% +$1.35K
ERF
4236
DELISTED
Enerplus Corporation
ERF
$14K ﹤0.01%
960
-18,300
-95% -$257K
EXPR
4237
DELISTED
Express, Inc.
EXPR
$14K ﹤0.01%
648
+49
+8% +$1.67K
LYT
4238
DELISTED
Lytus Technologies Holdings PTV. Ltd. Common Shares
LYT
$14K ﹤0.01%
151
-2
-1% -$333
PTRS
4239
DELISTED
Partners Bancorp Common Stock
PTRS
$14K ﹤0.01%
1,552
+810
+109% +$7.52K
SDC
4240
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$14K ﹤0.01%
15,044
+11,088
+280% +$13.5K
SAL
4241
DELISTED
Salisbury Bancorp, Inc.
SAL
$14K ﹤0.01%
568
-902
-61% -$21.4K
SGHLU
4242
DELISTED
Signal Hill Acquisition Corp. Unit
SGHLU
$14K ﹤0.01%
1,424
– –
ML
4243
DELISTED
MoneyLion Inc.
ML
$14K ﹤0.01%
522
-1,741
-77% -$79.8K
PEAR
4244
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$14K ﹤0.01%
+6,786
New +$11.5K
TBSA
4245
DELISTED
TB SA Acquisition Corp Class A Ordinary Share
TBSA
$14K ﹤0.01%
1,452
-5
-0.3% -$49
CNCE
4246
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$14K ﹤0.01%
2,047
-27,165
-93% -$165K
DTRTU
4247
DELISTED
DTRT Health Acquisition Corp. Unit
DTRTU
$14K ﹤0.01%
1,385
– –
QNGY
4248
DELISTED
Quanergy Systems, Inc.
QNGY
$14K ﹤0.01%
3,345
+2,583
+339% +$16.7K
WMC
4249
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$14K ﹤0.01%
1,281
-1,357
-51% -$18.1K
ABVC icon
4250
ABVC BioPharma
ABVC
$23.5M
$13K ﹤0.01%
1,510
+910
+152% +$7.65K
168 169
170
171 172

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.